Molecular portraits and trastuzumab responsiveness of estrogen receptor-positive, progesterone receptor-positive, and HER2-positive breast cancer

Background: Estrogen receptor-positive, progesterone receptor-positive, and HER2-positive breast cancers (triple-positive breast cancers, TPBCs) account for 5% to 10% of all breast cancers. The clinical and molecular features of TPBCs remain elusive. In this study, we aim to analyze the multiomics l...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Shen, Liu, Xi-Yu, Jin, Xi, Ma, Ding, Xiao, Yi, Shao, Zhi-Ming, Jiang, Yi-Zhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691389/
https://www.ncbi.nlm.nih.gov/pubmed/31410192
http://dx.doi.org/10.7150/thno.35730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691389/
https://www.ncbi.nlm.nih.gov/pubmed/31410192
http://dx.doi.org/10.7150/thno.35730

Ejemplares similares